pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Tag › disease-modifying drugs

    Key pathogenetic mechanisms of multiple sclerosis and the possibilities of target inthem: state of the problem

    Редактор | 2018, Original articles, Practical medicine part 16 №10 Neurology (2018) | 10 декабря, 2018

    T.I. KHAIBULLIN1,2, N.N. BABICHEVA1, G.M. AKHMEDOVA2, L.A. AVERIANOVA1, E.V. GRANATOV1, S.R. SHAKIRZANOVA1 1Republic Clinical-diagnostic Center for Demyelinating Diseases, 13 Vatutin Str., Kazan, Russian Federation, 420021 2Kazan State Medical Academy — Branch Campus of the FSBEI FPE RMACPE MOH Russia, 36 Butlerov Str., 420012 Kazan, Russian Federation  Khaybullin T.I. — PhD (medicine), Associate Professor of the […]

    Tag: 2018, disease-modifying drugs, E.V. GRANATOV, G.M. AKHMEDOVA, L.A. AVERIANOVA, multiple sclerosis, N.N. BABICHEVA, pathogenesis, Practical medicine part 16 №10 Neurology (2018), S.R. SHAKIRZANOVA, T.I. KHAIBULLIN, treatment
    Комментарии к записи Key pathogenetic mechanisms of multiple sclerosis and the possibilities of target inthem: state of the problem отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©